MX2021014582A - Derivados de diazepinona como moduladores del ensamblaje de la capside. - Google Patents
Derivados de diazepinona como moduladores del ensamblaje de la capside.Info
- Publication number
- MX2021014582A MX2021014582A MX2021014582A MX2021014582A MX2021014582A MX 2021014582 A MX2021014582 A MX 2021014582A MX 2021014582 A MX2021014582 A MX 2021014582A MX 2021014582 A MX2021014582 A MX 2021014582A MX 2021014582 A MX2021014582 A MX 2021014582A
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- capsid assembly
- assembly modulators
- diazepinone derivatives
- diazepinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
Se divulgan compuestos, composiciones y métodos de tratamiento de enfermedades, síndromes, afecciones y trastornos que están afectados por CAM del VHB. Dichos compuestos se representan por la fórmula (I) a continuación: (ver Fórmula) en donde R1, R2, R3, X y R4, se han definido en el presente documento.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962853533P | 2019-05-28 | 2019-05-28 | |
PCT/EP2020/064750 WO2020239863A1 (en) | 2019-05-28 | 2020-05-27 | Diazepinone derivatives as capsid assembly modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021014582A true MX2021014582A (es) | 2022-01-11 |
Family
ID=70968929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021014582A MX2021014582A (es) | 2019-05-28 | 2020-05-27 | Derivados de diazepinona como moduladores del ensamblaje de la capside. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220213102A1 (es) |
EP (1) | EP3976615A1 (es) |
JP (1) | JP2022534960A (es) |
KR (1) | KR20220015420A (es) |
CN (1) | CN113891889A (es) |
AU (1) | AU2020281804A1 (es) |
BR (1) | BR112021023710A2 (es) |
CA (1) | CA3136493A1 (es) |
MX (1) | MX2021014582A (es) |
WO (1) | WO2020239863A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201806956A (zh) * | 2016-06-29 | 2018-03-01 | 諾維拉治療公司 | 二氮呯酮衍生物及治療b型肝炎感染之方法 |
AU2017290755B2 (en) * | 2016-06-29 | 2021-07-01 | Novira Therapeutics, Inc. | Diazepinone derivatives and their use in the treatment of hepatitis B infections |
-
2020
- 2020-05-27 MX MX2021014582A patent/MX2021014582A/es unknown
- 2020-05-27 WO PCT/EP2020/064750 patent/WO2020239863A1/en unknown
- 2020-05-27 US US17/595,772 patent/US20220213102A1/en active Pending
- 2020-05-27 KR KR1020217042020A patent/KR20220015420A/ko unknown
- 2020-05-27 AU AU2020281804A patent/AU2020281804A1/en active Pending
- 2020-05-27 JP JP2021570714A patent/JP2022534960A/ja active Pending
- 2020-05-27 EP EP20729988.4A patent/EP3976615A1/en not_active Withdrawn
- 2020-05-27 CN CN202080039616.3A patent/CN113891889A/zh active Pending
- 2020-05-27 CA CA3136493A patent/CA3136493A1/en active Pending
- 2020-05-27 BR BR112021023710A patent/BR112021023710A2/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN113891889A (zh) | 2022-01-04 |
JP2022534960A (ja) | 2022-08-04 |
WO2020239863A1 (en) | 2020-12-03 |
US20220213102A1 (en) | 2022-07-07 |
EP3976615A1 (en) | 2022-04-06 |
AU2020281804A1 (en) | 2021-11-25 |
CA3136493A1 (en) | 2020-05-27 |
BR112021023710A2 (pt) | 2022-04-12 |
KR20220015420A (ko) | 2022-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2019000192A1 (en) | Pyrazole derivatives as malt1 inhibitors | |
PH12021500014A1 (en) | Fused ring compounds | |
WO2020097537A3 (en) | Fused ring compounds | |
PH12020552207A1 (en) | Pyrazole derivatives as malt1 inhibitors | |
EP4234031A3 (en) | C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors | |
MX2020006290A (es) | Dinucleotidos ciclicos como agonistas de sting. | |
MX2023001876A (es) | Derivados de rapamicina. | |
CR20210247A (es) | Nuevos compuestos heterocíclicos | |
MX2020013699A (es) | Derivados de pirazol como inhibidores de malt1. | |
MX2021014350A (es) | Compuestos de 1-oxo-isoindolin-5-carboxamida sustituida, composiciones de los mismos y metodos de tratamiento con los mismos. | |
MX2021012706A (es) | Inhibidores de dihidroorotato deshidrogenasa. | |
MX2020010949A (es) | Nuevos compuestos y derivados de sulfonimidoilpurinona para el tratamiento y profilaxis de infecciones viricas. | |
PH12020552172A1 (en) | Cyclic dinucleotides as sting agonists | |
MX2020008746A (es) | Compuestos de sulfonimidoilpurinona 7-sustituidos y sus derivados para el tratamiento y prevencion del cancer de higado. | |
CR20220004A (es) | Nuevos compuestos heterocíclicos | |
CR20230382A (es) | Derivados de tetrahidroazepina bicíclicos para el tratamiento del cáncer | |
MX2020013827A (es) | Proceso de preparacion de compuestos triciclicos. | |
MX2021014580A (es) | Derivados heterociclos condensados como moduladores de ensamblaje de la capside. | |
MX2022002446A (es) | Compuestos de pirrolopirimidina inhibidores de perk. | |
MX2021014582A (es) | Derivados de diazepinona como moduladores del ensamblaje de la capside. | |
MX2021012417A (es) | Anillos de piridina que contienen derivados como inhibidores de malt1. | |
EP4169925A3 (en) | Process to make n-substituted tetrahydrothienopyridine derivatives | |
MX2021014578A (es) | Azepinas como moduladores del ensamblaje de la cápside del vhb. | |
MX2022002443A (es) | Compuestos inhibidores de perk. | |
MX2021014577A (es) | Difluoroazepanos como moduladores del ensamblaje de la cápside del vhb. |